Shandong Weigao Group Medical Polymer Company Limited

SHWGF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$2,554$2,369$3,318$2,842
Dep. & Amort.$972$912$803$724
Deferred Tax$0$0$0-$452
Stock-Based Comp.$36$55$92$76
Change in WC-$292-$315-$1,137-$205
Other Non-Cash-$480-$223-$861$50
Operating Cash Flow$2,790$2,799$2,215$3,035
Investing Activities
PP&E Inv.-$598-$648-$1,116-$1,117
Net Acquisitions-$31-$43-$159-$10
Inv. Purchases-$4,405-$2,000-$1,473-$38
Inv. Sales/Matur.$3,561$1,271$0$4
Other Inv. Act.$368$31$180-$318
Investing Cash Flow-$1,104-$1,389-$2,569-$1,479
Financing Activities
Debt Repay.-$102-$365$93-$197
Stock Issued-$30$0$0$188
Stock Repurch.$0-$37-$35$0
Dividends Paid-$871-$733-$742-$653
Other Fin. Act.-$593-$1,024-$337$114
Financing Cash Flow-$1,596-$2,158-$1,021-$548
Forex Effect$56$24$96-$54
Net Chg. in Cash$145-$724-$1,279$963
Supplemental Information
Beg. Cash$4,797$5,521$6,698$5,666
End Cash$4,943$4,797$5,419$6,629
Free Cash Flow$2,143$2,113$1,098$1,918
Shandong Weigao Group Medical Polymer Company Limited (SHWGF) Financial Statements & Key Stats | AlphaPilot